Skip to Content

Daridorexant FDA Approval Status

FDA Approved: No
Generic name: daridorexant
Company: Idorsia Ltd.
Treatment for: Insomnia

Daridorexant is a dual orexin receptor antagonist (DORA) in development for the treatment of insomnia.

Development Timeline for daridorexant

DateArticle
Mar 10, 2021FDA Accepts the New Drug Application for Review of Idorsia’s Daridorexant for the Treatment of Adult Patients with Insomnia
Jul  6, 2020Idorsia Announces Positive Results in the Second Phase 3 Study of Daridorexant

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.